Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD and establish how the chronic lung disease progresses.

COPD is caused by damage to the lungs or airways that can lead ... “There’s a variety of different inhalers to use for that, ...

Verona Pharma has seen its share price skyrocket in anticipation of the commercial launch of its COPD treatment.

As the air pollution levels in the national capital reach very poor the doctors say that people with no history of ...

Winter is prime time for COPD. You can’t get rid of the disease, but treatment can improve quality of life.Key takeaways:COPD ...

Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...

Q3 2024 Earnings Call Transcript November 4, 2024 Verona Pharma plc beats earnings expectations. Reported EPS is $-0.08819, ...

Verona Pharma (Nasdaq: VRNA) is already recording millions of dollars in revenue after launching its lead drug in August ...

Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3 Through October more ...

Do cough, cold or other respiratory issues disrupt your sleep in the rising air pollution? Explore the best nebulizer ...

NCR has given rise to the use of nebulizers among children who are having it tough to breathe. Most hospitals are crowded with children struggling to breathe. Many have asthma or pneumonia, conditions ...

Nebulizers are commonly used in patients with ... She is a clinical pharmacy specialist in pulmonary/critical care, Department of Pharmaceutical Care at the University of Texas Medical Branch ...